Skip to main navigation

Press Releases

Keyword Search

Year

June 10, 2021

Catalyst Biosciences to Participate in Two Upcoming Investor Conferences

May 18, 2021

Catalyst Biosciences Announces First Patient Dosed in Marzeptacog Alfa (Activated) Phase 1/2 Study in Factor VII Deficiency, Glanzmann Thrombasthenia and Hemophilia A treated with Hemlibra

May 13, 2021

Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit

May 6, 2021

Catalyst Biosciences Reports First Quarter 2021 Operating & Financial Results and Provides a Corporate Update

May 5, 2021

Catalyst Biosciences Announces First Patient Dosed in Pivotal Phase 3 Registration Study of SQ MarzAA in Individuals with Hemophilia A or B with Inhibitors

April 19, 2021

Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene Therapy Data in Blood, the Journal of the American Society of Hematology

April 12, 2021

Catalyst Biosciences Expands its Protease Medicines Patent Portfolio of Complement Factor 3 Degraders

April 7, 2021

Catalyst Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference

March 4, 2021

Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update

February 18, 2021

Catalyst Biosciences to Present at the 42nd Annual Raymond James Institutional Investors Conference

February 11, 2021

Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock

February 3, 2021

Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress

January 29, 2021

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

January 27, 2021

Catalyst Biosciences Announces Pricing of Public Offering of Common Stock

January 26, 2021

Catalyst Biosciences Announces Proposed Public Offering of Common Stock

January 20, 2021

Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress

January 15, 2021

Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital

Shareholder Tools

Print Page
RSS Feeds
E-mail Alerts

Investor Relations

Overview
Press Releases
Events and Presentations
- Scientific Presentations and Publications
Financials & Filings
Stock Information
Corporate Governance
Investor FAQ
Contact Us

Shareholder Tools

Print Page
RSS Feeds
E-mail Alerts

About
Pipeline
Science
- Scientific Presentations and Publications
News
Investors
Investor header menu
Careers
- Benefits
- Values

Home
Contact

Home
Contact
About
Pipeline
Science
- Scientific Presentations and Publications
News
Investors
Careers
- Benefits
- Values
Terms of Use
Privacy Policy
Cookie Notice
LinkedIn

© 2021 Catalyst BiosciencesAll rights reservedWebsite Design: Hane Chow, Inc.

Terms of Use
Privacy Policy
Cookie Notice
LinkedIn
Twitter
Facebook